Earlier this year, when US President Donald Trump offered to buy Greenland from Denmark, online rumours circulated that the Danish government might encourage Novo Nordisk, the Danish company behind ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

He’s the CEO of Danish pharmaceutical firm Novo Nordisk — best known as the maker of Ozempic and Wegovy, the blockbuster diabetes and weight-loss drugs-turned-cultural phenomena that have ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

Trump’s comments about purchasing the island sent shock waves through the Danish territory, and enlivened its independence ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. Ozempic and other GLP-1 drugs like it ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. Before Naveini Vasikaran started ...

The cost of Ozempic can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Ozempic. Ozempic belongs to a ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.